Pay in 4 interest-free payments of $6.89 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Are GLP-1s a safe way to lose weight
Tirzepatide represents a dual agonist, activating both GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) receptors, which may explain its particularly robust weight loss effects
Tirzepatide is a dual-action medication that activates both GLP-1 and GIP receptors
Ipamorelin is a growth hormone-releasing peptide (GHRP) a ghrelin mimetic that amplifies that GH pulse without significantly increasing cortisol or prolactin (a key advantage over older GHRPs like GHRP-2 or GHRP-6)
Do not use a preparation that has been frozen or that you suspect may have been frozen, and do not attempt to re-refrigerate a thawed product
On This Page Indications and Usage Dosage and Administration Dosage Forms and Strengths Contraindications Warnings and Precautions Adverse Reactions/Side Effects Drug Interactions Use In Specific Populations Overdosage Description Clinical Pharmacology Nonclinical Toxicology Clinical Studies How Supplied/Storage and Handling Patient Counseling Information Medication Guide Highlights of Prescribing Information WEGOVY (semaglutide) injection, for subcutaneous use WEGOVY (semaglutide) tablets, for oral use Initial U.S
US$ 26.90
US$ 27.15
US$ 25.25
US$ 23.96
US$ 28.29
US$ 20.97
